Cognitive Dysfunction Mechanisms in Schizophrenia Models

Cognitive dysfunction in schizophrenia remains a critical barrier to functional recovery, with animal and cellular models converging on molecular, synaptic and circuit-level disturbances. Hypofunction of N-methyl-D-aspartate receptors on cortical and hippocampal interneurons disrupts excitatory/inhibitory balance, leading to excessive glutamatergic drive and impaired gamma-band synchrony. Synaptic integrity is compromised by reduced dendritic spine density and altered Akt–GSK3-mediated plasticity, undermining learning and memory. Disrupted oscillatory coupling between the medial prefrontal cortex and hippocampus impairs information encoding and retrieval, while aberrant thalamocortical and ventral hippocampal pathways exacerbate cognitive inflexibility. Emerging evidence also implicates astrocyte and microglial activation, oxidative stress and neurodevelopmental alterations in amplifying neural dysfunction. These models identify molecular targets and network dynamics essential for designing circuit-specific interventions to ameliorate cognitive deficits.

Research from Nature Portfolio

Studies have demonstrated that the antipsychotic olanzapine prevents phencyclidine-induced reduction of neurite outgrowth and synaptic protein expression in primary prefrontal cortical neurons by engaging neuregulin-1-dependent activation of the Akt–GSK3 signalling cascade. This work highlights how restoring dendritic architecture and intracellular plasticity pathways can underpin recovery of cognitive function in receptor-hypofunction models.

Cognitive Dysfunction Mechanisms in Schizophrenia Models publication trend

The graph below shows the total number of articles in cognitive dysfunction mechanisms in schizophrenia models across all publications each year (not limited to Nature Index journals).

Technical terms

N-methyl-D-aspartate receptor (NMDAR): An ionotropic glutamate receptor essential for synaptic plasticity and memory formation.

Gamma oscillations: Fast (30–80 Hz) brain rhythms reflecting local excitatory/inhibitory interactions, crucial for information binding.

Positive allosteric modulator (PAM): A compound that enhances receptor response to its endogenous ligand without directly activating the receptor.

Neuregulin-1 (NRG1): A trophic factor involved in neurite development and synaptic maintenance via ErbB receptor signalling.

Hypoglutamatergic hypothesis: The theory that reduced glutamate transmission at NMDARs contributes to schizophrenia pathophysiology.

References

1. Olanzapine Prevents the PCP-induced Reduction in the Neurite Outgrowth of Prefrontal Cortical Neurons via NRG1. Scientific Reports (2016).
2. Advances in the study of phencyclidine-induced schizophrenia-like animal models and the underlying neural mechanisms. Schizophrenia (2024).
3. Oscillatory Deficits in the Sub-Chronic PCP Rat Model for Schizophrenia Are Reversed by mGlu5 Receptor-Positive Allosteric Modulators VU0409551 and VU0360172. Cells (2023).
4. Neural substrates of cognitive impairment in a NMDAR hypofunction mouse model of schizophrenia and partial rescue by risperidone. Frontiers in Cellular Neuroscience (2023).